Amy Grover

Amy Grover has extensive experience in the field of patient advocacy, currently serving as the Executive Director of Patient Advocacy at Catalyst Pharmaceuticals, Inc., a position held since 2018. Prior to this role, Amy held multiple positions within the same organization, including Senior Director of Patient Advocacy and Director of Patient Advocacy. Additionally, from October 2008 to February 2024, Amy contributed significantly to Global Genes - Allies in Rare Disease as the Director of Operations.